Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1553, 2006-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Fludarabine + cyclophosphamide effective for CLL
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. :
Cyclophosphamide + paclitaxel effective in PBPC mobilisation
Inpharma, Vol. 1, Iss. 1222, 2000-01 ,pp. :
Alemtuzumab: an effective front-line option for CLL?
Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. :
R-FC cost effective for CLL on both sides of Atlantic
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :